Edesa Biotech, Inc(NASDAQ:EDSA) 
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 2/Phase...
Website: http://www.edesabiotech.com
Founded: 2007
Full Time Employees: 12
CEO: Pardeep Nijhawan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.31
H 2.31
L 2.20
C 2.31
V 2,386
10EMA 2.31
20EMA 2.31
60EMA 2.31
120EMA 2.31
250EMA 2.31